Individual Study / Genomic data with clinical outcome data from routine practice data from Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA

Genomic data with clinical outcome data from routine practice data from Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA

Genomic data with clinical outcome data from routine practice data from Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA

Initiatives -
Genomic data and its application to clinical use, molecular tumor boards with diverse expertise can provide guidance to oncologists and patients seeking to implement personalized genetically targeted therapy in practice.
Start Year
2013
End Year
2016
Funding
National Cancer Institute Grant No. P30 CA006973 to the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center.
Visit Genomic data with clinical outcome data from routine practice data from Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA

Members

Download
Investigators Contacts
  • Dr. Josh Lauring
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Design

Study design
Patients' cohort
Follow Up
A median follow-up of 7 months

Marker Paper

Dalton WB, Forde PM, Kang H, Connolly RM, Stearns V, Gocke CD, Eshleman JR, Axilbund J, Petry D, Geoghegan C, Wolff AC, Loeb DM, Pratilas CA, Meyer CF, Christenson ES, Slater SA, Ensminger J, Parsons HA, Park BH, Lauring J. Personalized Medicine in the Oncology Clinic: Implementation and Outcomes of the Johns Hopkins Molecular Tumor Board. JCO Precis Oncol. 2017;2017:PO.16.00046. doi: 10.1200/PO.16.00046. Epub 2017 May 31.

PUBMED 30003184

Recruitment

Sources of Recruitment
  • Individuals

Number of participants

Number of participants
155
Number of participants with biosamples

Access

Availability of data and biosamples

Data
Biosamples
Other